346 related articles for article (PubMed ID: 21246504)
1. Improved product-per-glucose yields in P450-dependent propane biotransformations using engineered Escherichia coli.
Fasan R; Crook NC; Peters MW; Meinhold P; Buelter T; Landwehr M; Cirino PC; Arnold FH
Biotechnol Bioeng; 2011 Mar; 108(3):500-10. PubMed ID: 21246504
[TBL] [Abstract][Full Text] [Related]
2. Analysis of NADPH supply during xylitol production by engineered Escherichia coli.
Chin JW; Khankal R; Monroe CA; Maranas CD; Cirino PC
Biotechnol Bioeng; 2009 Jan; 102(1):209-20. PubMed ID: 18698648
[TBL] [Abstract][Full Text] [Related]
3. P450(BM-3)-catalyzed whole-cell biotransformation of alpha-pinene with recombinant Escherichia coli in an aqueous-organic two-phase system.
Schewe H; Holtmann D; Schrader J
Appl Microbiol Biotechnol; 2009 Jul; 83(5):849-57. PubMed ID: 19266193
[TBL] [Abstract][Full Text] [Related]
4. Subtoxic product levels limit the epoxidation capacity of recombinant E. coli by increasing microbial energy demands.
Kuhn D; Fritzsch FS; Zhang X; Wendisch VF; Blank LM; Bühler B; Schmid A
J Biotechnol; 2013 Jan; 163(2):194-203. PubMed ID: 22922011
[TBL] [Abstract][Full Text] [Related]
5. Improved NADPH supply for xylitol production by engineered Escherichia coli with glycolytic mutations.
Chin JW; Cirino PC
Biotechnol Prog; 2011; 27(2):333-41. PubMed ID: 21344680
[TBL] [Abstract][Full Text] [Related]
6. Improvement of P450(BM-3) whole-cell biocatalysis by integrating heterologous cofactor regeneration combining glucose facilitator and dehydrogenase in E. coli.
Schewe H; Kaup BA; Schrader J
Appl Microbiol Biotechnol; 2008 Feb; 78(1):55-65. PubMed ID: 18057930
[TBL] [Abstract][Full Text] [Related]
7. Increased NADPH availability in Escherichia coli: improvement of the product per glucose ratio in reductive whole-cell biotransformation.
Siedler S; Bringer S; Bott M
Appl Microbiol Biotechnol; 2011 Dec; 92(5):929-37. PubMed ID: 21670981
[TBL] [Abstract][Full Text] [Related]
8. Enhanced production of GDP-L-fucose by overexpression of NADPH regenerator in recombinant Escherichia coli.
Lee WH; Chin YW; Han NS; Kim MD; Seo JH
Appl Microbiol Biotechnol; 2011 Aug; 91(4):967-76. PubMed ID: 21538115
[TBL] [Abstract][Full Text] [Related]
9. Engineering Escherichia coli for efficient cellobiose utilization.
Vinuselvi P; Lee SK
Appl Microbiol Biotechnol; 2011 Oct; 92(1):125-32. PubMed ID: 21713510
[TBL] [Abstract][Full Text] [Related]
10. Design of a cytochrome P450BM3 reaction system linked by two-step cofactor regeneration catalyzed by a soluble transhydrogenase and glycerol dehydrogenase.
Mouri T; Shimizu T; Kamiya N; Goto M; Ichinose H
Biotechnol Prog; 2009; 25(5):1372-8. PubMed ID: 19725101
[TBL] [Abstract][Full Text] [Related]
11. High NADPH/NADP+ ratio improves thymidine production by a metabolically engineered Escherichia coli strain.
Lee HC; Kim JS; Jang W; Kim SY
J Biotechnol; 2010 Aug; 149(1-2):24-32. PubMed ID: 20600382
[TBL] [Abstract][Full Text] [Related]
12. Effect of different levels of NADH availability on metabolic fluxes of Escherichia coli chemostat cultures in defined medium.
Sánchez AM; Bennett GN; San KY
J Biotechnol; 2005 Jun; 117(4):395-405. PubMed ID: 15925720
[TBL] [Abstract][Full Text] [Related]
13. Engineering of recombinant E. coli cells co-expressing P450pyrTM monooxygenase and glucose dehydrogenase for highly regio- and stereoselective hydroxylation of alicycles with cofactor recycling.
Pham SQ; Gao P; Li Z
Biotechnol Bioeng; 2013 Feb; 110(2):363-73. PubMed ID: 22886996
[TBL] [Abstract][Full Text] [Related]
14. Metabolic engineering of Escherichia coli: construction of an efficient biocatalyst for D-mannitol formation in a whole-cell biotransformation.
Kaup B; Bringer-Meyer S; Sahm H
Appl Microbiol Biotechnol; 2004 Apr; 64(3):333-9. PubMed ID: 14586579
[TBL] [Abstract][Full Text] [Related]
15. Succinic acid production with metabolically engineered E. coli recovered from two-stage fermentation.
Ma JF; Jiang M; Chen KQ; Xu B; Liu SW; Wei P; Ying HJ
Biotechnol Lett; 2010 Oct; 32(10):1413-8. PubMed ID: 20495946
[TBL] [Abstract][Full Text] [Related]
16. Comparison between Escherichia coli K-12 strains W3110 and MG1655 and wild-type E. coli B as platforms for xylitol production.
Khankal R; Luziatelli F; Chin JW; Frei CS; Cirino PC
Biotechnol Lett; 2008 Sep; 30(9):1645-53. PubMed ID: 18414795
[TBL] [Abstract][Full Text] [Related]
17. Engineering the pentose phosphate pathway to improve hydrogen yield in recombinant Escherichia coli.
Kim YM; Cho HS; Jung GY; Park JM
Biotechnol Bioeng; 2011 Dec; 108(12):2941-6. PubMed ID: 21732330
[TBL] [Abstract][Full Text] [Related]
18. Quantification of metabolic limitations during recombinant protein production in Escherichia coli.
Heyland J; Blank LM; Schmid A
J Biotechnol; 2011 Sep; 155(2):178-84. PubMed ID: 21723332
[TBL] [Abstract][Full Text] [Related]
19. NADPH-dependent reductive biotransformation with Escherichia coli and its pfkA deletion mutant: influence on global gene expression and role of oxygen supply.
Siedler S; Bringer S; Polen T; Bott M
Biotechnol Bioeng; 2014 Oct; 111(10):2067-75. PubMed ID: 24771245
[TBL] [Abstract][Full Text] [Related]
20. Metabolic and transcriptional response of Escherichia coli with a NADP(+)-dependent glyceraldehyde 3-phosphate dehydrogenase from Streptococcus mutans.
Centeno-Leija S; Utrilla J; Flores N; Rodriguez A; Gosset G; Martinez A
Antonie Van Leeuwenhoek; 2013 Dec; 104(6):913-24. PubMed ID: 23989925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
